Patient characteristics at the time of blood and bone marrow sampling for this study
| Patient . | Age, y . | Sex . | MM stage, Durie & Salmon . | MM type . |
|---|---|---|---|---|
| 1 | 41 | Male | III | IgG-λ |
| 2 | 80 | Male | I | IgG-λ |
| 3 | 80 | Male | III | Light chain-λ |
| 4 | 75 | Female | II | IgG-λ |
| 5 | 66 | Female | II | IgG-λ |
| 6 | 53 | Female | I | IgG-κ |
| 7 | 64 | Male | II | Light chain-κ |
| Patient . | Age, y . | Sex . | MM stage, Durie & Salmon . | MM type . |
|---|---|---|---|---|
| 1 | 41 | Male | III | IgG-λ |
| 2 | 80 | Male | I | IgG-λ |
| 3 | 80 | Male | III | Light chain-λ |
| 4 | 75 | Female | II | IgG-λ |
| 5 | 66 | Female | II | IgG-λ |
| 6 | 53 | Female | I | IgG-κ |
| 7 | 64 | Male | II | Light chain-κ |
All the patients included in this study were newly diagnosed and had not yet started any treatment regimen at sampling time.